Quidel Cp (QDEL) 19.44 $QDEL
Upgrade Alert for Quidel (QDEL)
Comtex SmarTrend(R) - Tue Jun 14, 3:32AM CDT
Quidel (NASDAQ:QDEL) was upgraded from Market Perform to Outperform at Raymond James today. The stock closed yesterday at $18.10 on volume of 223,000 shares, above average daily volume of 153,000. Quidel Corporation discovers, develops, manufactures, and markets rapid diagnostic products for point-of-care detection of human medical conditions and illnesses. The Company's products provide diagnoses for acute and chronic conditions in the areas of women's health and infectious diseases. Quidel's products are sold to professionals and to consumers.
QDEL: 19.44 (+0.81)
Quidel to Present at the Bank of America Merrill Lynch 2016 Health Care Conference
Marketwired - Thu Apr 28, 3:00PM CDT
Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that it will present at the Bank of America Merrill Lynch 2016 Health Care Conference, to be held at the Encore at Wynn hotel in Las Vegas, Nevada on Tuesday, May 10, 2016.
QDEL: 19.44 (+0.81)
Quidel reports 1Q loss
Automated Insights - Wed Apr 27, 5:31PM CDT
SAN DIEGO (AP) _ Quidel Corp. (QDEL) on Wednesday reported a first-quarter loss of $3.4 million, after reporting a profit in the same period a year earlier.
QDEL: 19.44 (+0.81)
Quidel Reports First Quarter 2016 Financial Results
Marketwired - Wed Apr 27, 3:10PM CDT
Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today financial results for the first quarter ended March 31, 2016.
QDEL: 19.44 (+0.81)
Q1 Earnings Lack Sheen: 5 MedTech Stocks to Bet On
Zacks Equity Research - Zacks Investment Research - Wed Apr 13, 3:55PM CDT
Medical is one of the few sectors in the S&P 500 that is expected to report growth in the first quarter.
ZBH: 124.89 (+2.87), ALGN: 82.93 (+1.04), GKOS: 29.24 (+0.28), QDEL: 19.44 (+0.81), INGN: 51.91 (-0.49)
Quidel to Hold First Quarter 2016 Financial Results Conference Call on April 27, 2016
Marketwired - Tue Apr 12, 3:30PM CDT
Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, will report first quarter 2016 financial results after market close on Wednesday, April 27, 2016.
QDEL: 19.44 (+0.81)
18.8% Return Seen to Date on SmarTrend Quidel Call (QDEL)
Comtex SmarTrend(R) - Wed Feb 10, 12:40PM CST
SmarTrend identified a Downtrend for Quidel (NASDAQ:QDEL) on January 7th, 2016 at $19.12. In approximately 1 month, Quidel has returned 18.78% as of today's recent price of $15.53.
QDEL: 19.44 (+0.81)
Downgrade Alert for Quidel (QDEL)
Comtex SmarTrend(R) - Tue Feb 09, 7:13AM CST
Quidel (NASDAQ:QDEL) was downgraded from Buy to Hold at Canaccord Genuity today. The stock closed yesterday at $16.34 on volume of 285,000 shares, above average daily volume of 279,000. Quidel Corporation discovers, develops, manufactures, and markets rapid diagnostic products for point-of-care detection of human medical conditions and illnesses. The Company's products provide diagnoses for acute and chronic conditions in the areas of women's health and infectious diseases. Quidel's products are sold to professionals and to consumers.
QDEL: 19.44 (+0.81)
Quidel Announces Preliminary Revenue for Fourth Quarter 2015
Marketwired - Thu Jan 07, 5:37PM CST
Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that it expects revenues in the fourth quarter of 2015 to be between $52 million and $53 million.
QDEL: 19.44 (+0.81)
Can Quidel Corp. (QDEL) Keep the Earnings Streak Alive This Quarter?
Zacks Equity Research - Zacks Investment Research - Thu Dec 17, 7:38AM CST
Quidel Corp. (QDEL) has seen a nice short-term history of beating earnings estimates, and looks set to crush analyst expectations in its next earnings report.
QDEL: 19.44 (+0.81)
Quidel Reports Third Quarter 2015 Financial Results
Marketwired - Wed Oct 28, 3:10PM CDT
Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today financial results for the third quarter ended September 30, 2015.
QDEL: 19.44 (+0.81)
Quidel Down 21.5% Since SmarTrend Downtrend Call (QDEL)
Comtex SmarTrend(R) - Wed Oct 28, 10:47AM CDT
SmarTrend identified a Downtrend for Quidel (NASDAQ:QDEL) on July 28th, 2015 at $22.11. In approximately 3 months, Quidel has returned 21.54% as of today's recent price of $17.35.
QDEL: 19.44 (+0.81)
Shares of QDEL Down 21.4% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Wed Oct 28, 10:22AM CDT
SmarTrend identified a Downtrend for Quidel (NASDAQ:QDEL) on July 28th, 2015 at $22.11. In approximately 3 months, Quidel has returned 21.39% as of today's recent price of $17.38.
QDEL: 19.44 (+0.81)
Shares of QDEL Down 16.6% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Wed Oct 21, 9:25AM CDT
SmarTrend identified a Downtrend for Quidel (NASDAQ:QDEL) on July 28th, 2015 at $22.11. In approximately 3 months, Quidel has returned 16.55% as of today's recent price of $18.45.
QDEL: 19.44 (+0.81)
Downtrend Call Working As Quidel Stock Falls 14.0% (QDEL)
Comtex SmarTrend(R) - Tue Oct 06, 11:38AM CDT
SmarTrend identified a Downtrend for Quidel (NASDAQ:QDEL) on July 28th, 2015 at $22.11. In approximately 2 months, Quidel has returned 14.02% as of today's recent price of $19.01.
QDEL: 19.44 (+0.81)
Can Quidel (QDEL) Keep the Earnings Streak Alive This Quarter?
Zacks Equity Research - Zacks Investment Research - Thu Sep 24, 7:48AM CDT
Quidel in the Medical Products space might be in a good position to beat earnings at its next report
QDEL: 19.44 (+0.81)
Upgrade Alert for Quidel (QDEL)
Comtex SmarTrend(R) - Tue Jun 14, 3:32AM CDT
Quidel (NASDAQ:QDEL) was upgraded from Market Perform to Outperform at Raymond James today. The stock closed yesterday at $18.10 on volume of 223,000 shares, above average daily volume of 153,000. Quidel Corporation discovers, develops, manufactures, and markets rapid diagnostic products for point-of-care detection of human medical conditions and illnesses. The Company's products provide diagnoses for acute and chronic conditions in the areas of women's health and infectious diseases. Quidel's products are sold to professionals and to consumers.
QDEL: 19.44 (+0.81)
Quidel to Present at the Bank of America Merrill Lynch 2016 Health Care Conference
Marketwired - Thu Apr 28, 3:00PM CDT
Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that it will present at the Bank of America Merrill Lynch 2016 Health Care Conference, to be held at the Encore at Wynn hotel in Las Vegas, Nevada on Tuesday, May 10, 2016.
QDEL: 19.44 (+0.81)
Quidel reports 1Q loss
Automated Insights - Wed Apr 27, 5:31PM CDT
SAN DIEGO (AP) _ Quidel Corp. (QDEL) on Wednesday reported a first-quarter loss of $3.4 million, after reporting a profit in the same period a year earlier.
QDEL: 19.44 (+0.81)
Quidel Reports First Quarter 2016 Financial Results
Marketwired - Wed Apr 27, 3:10PM CDT
Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today financial results for the first quarter ended March 31, 2016.
QDEL: 19.44 (+0.81)
Q1 Earnings Lack Sheen: 5 MedTech Stocks to Bet On
Zacks Equity Research - Zacks Investment Research - Wed Apr 13, 3:55PM CDT
Medical is one of the few sectors in the S&P 500 that is expected to report growth in the first quarter.
ZBH: 124.89 (+2.87), ALGN: 82.93 (+1.04), GKOS: 29.24 (+0.28), QDEL: 19.44 (+0.81), INGN: 51.91 (-0.49)
Quidel to Hold First Quarter 2016 Financial Results Conference Call on April 27, 2016
Marketwired - Tue Apr 12, 3:30PM CDT
Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, will report first quarter 2016 financial results after market close on Wednesday, April 27, 2016.
QDEL: 19.44 (+0.81)
18.8% Return Seen to Date on SmarTrend Quidel Call (QDEL)
Comtex SmarTrend(R) - Wed Feb 10, 12:40PM CST
SmarTrend identified a Downtrend for Quidel (NASDAQ:QDEL) on January 7th, 2016 at $19.12. In approximately 1 month, Quidel has returned 18.78% as of today's recent price of $15.53.
QDEL: 19.44 (+0.81)
Downgrade Alert for Quidel (QDEL)
Comtex SmarTrend(R) - Tue Feb 09, 7:13AM CST
Quidel (NASDAQ:QDEL) was downgraded from Buy to Hold at Canaccord Genuity today. The stock closed yesterday at $16.34 on volume of 285,000 shares, above average daily volume of 279,000. Quidel Corporation discovers, develops, manufactures, and markets rapid diagnostic products for point-of-care detection of human medical conditions and illnesses. The Company's products provide diagnoses for acute and chronic conditions in the areas of women's health and infectious diseases. Quidel's products are sold to professionals and to consumers.
QDEL: 19.44 (+0.81)
Quidel Announces Preliminary Revenue for Fourth Quarter 2015
Marketwired - Thu Jan 07, 5:37PM CST
Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that it expects revenues in the fourth quarter of 2015 to be between $52 million and $53 million.
QDEL: 19.44 (+0.81)
Can Quidel Corp. (QDEL) Keep the Earnings Streak Alive This Quarter?
Zacks Equity Research - Zacks Investment Research - Thu Dec 17, 7:38AM CST
Quidel Corp. (QDEL) has seen a nice short-term history of beating earnings estimates, and looks set to crush analyst expectations in its next earnings report.
QDEL: 19.44 (+0.81)
Quidel Reports Third Quarter 2015 Financial Results
Marketwired - Wed Oct 28, 3:10PM CDT
Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today financial results for the third quarter ended September 30, 2015.
QDEL: 19.44 (+0.81)
Quidel Down 21.5% Since SmarTrend Downtrend Call (QDEL)
Comtex SmarTrend(R) - Wed Oct 28, 10:47AM CDT
SmarTrend identified a Downtrend for Quidel (NASDAQ:QDEL) on July 28th, 2015 at $22.11. In approximately 3 months, Quidel has returned 21.54% as of today's recent price of $17.35.
QDEL: 19.44 (+0.81)
Shares of QDEL Down 21.4% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Wed Oct 28, 10:22AM CDT
SmarTrend identified a Downtrend for Quidel (NASDAQ:QDEL) on July 28th, 2015 at $22.11. In approximately 3 months, Quidel has returned 21.39% as of today's recent price of $17.38.
QDEL: 19.44 (+0.81)
Shares of QDEL Down 16.6% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Wed Oct 21, 9:25AM CDT
SmarTrend identified a Downtrend for Quidel (NASDAQ:QDEL) on July 28th, 2015 at $22.11. In approximately 3 months, Quidel has returned 16.55% as of today's recent price of $18.45.
QDEL: 19.44 (+0.81)
Downtrend Call Working As Quidel Stock Falls 14.0% (QDEL)
Comtex SmarTrend(R) - Tue Oct 06, 11:38AM CDT
SmarTrend identified a Downtrend for Quidel (NASDAQ:QDEL) on July 28th, 2015 at $22.11. In approximately 2 months, Quidel has returned 14.02% as of today's recent price of $19.01.
QDEL: 19.44 (+0.81)
Can Quidel (QDEL) Keep the Earnings Streak Alive This Quarter?
Zacks Equity Research - Zacks Investment Research - Thu Sep 24, 7:48AM CDT
Quidel in the Medical Products space might be in a good position to beat earnings at its next report
QDEL: 19.44 (+0.81)
